Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
Author:
Funder
Barts Charity
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference242 articles.
1. Vitamin C supplementation improve the sputum conversion culture rate in pulmonary tuberculosis treatment while rifampicin susceptible;Susanto;IOP Conf. Ser.: Earth Environ. Sci.,2018
2. Global tuberculosis report 2020 – Reflections on the Global TB burden, treatment and prevention efforts;Chakaya;Int. J. Infect. Dis.,2021
3. Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline;Nahid;Am. J. Respir. Crit. Care Med.,2019
4. CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis;Hasan;PLoS One,2009
5. Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis;Su;Clin. Vaccin. Immunol.,2010
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia;Frontiers in Immunology;2023-12-12
2. Necrosis, netosis, and apoptosis in pulmonary tuberculosis and type-2 diabetes mellitus. Clues from the patient's serum;Tuberculosis;2023-12
3. Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis;Biomedicine & Pharmacotherapy;2023-12
4. High and Low Levels of ABCB1 Expression Are Associated with Two Distinct Gene Signatures in Lung Tissue of Pulmonary TB Patients with High Inflammation Activity;International Journal of Molecular Sciences;2023-10-02
5. Granulocytes subsets and their divergent functions in host resistance to Mycobacterium tuberculosis — a ‘tipping-point’ model of disease exacerbation;Current Opinion in Immunology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3